ohhhhh.... very nice. Finally some action. In res

ohhhhh.... very nice. Finally some action.

In response to Thomas Ichim,

Hello Thom,

Thank you for your prompt reply!

I'm unsure as to when is best to call, but if we can save each other the difficulty of time zones

Most of my information regarding the company has been accumulated through the internet (various FDA websites, PR events, bioregen pharma website, etc etc.

The share price of BMSN fell quite heavily amid dilution since the start of april, bringing the share structure to A/S 2 Billion, O/S 1.7 Billion from 1.2 Billion (I believe).  This has many shareholders in a panic, and have claims such as that HemaXellerate was a failure, and BMSN stock is being used as personal financing for David Koos.  (I know many of these claims are absurd, but I still would like to have a comprehensive cover)
(also- share price has plumetted from 1.6c/share to .03c/share.  Is this money being used to fund clinical trials, or David Koos pockets?)

Also, there are claims that the company is going bankrupt.  Is there any legitimacy to this claim?

Many people are claiming the IND # for HemaXellerate to be fraudulent due to lacking a digit.   Many in the online community would be happy to have an updated number that is appropriate to the drug (unless I have been mislead- and only with your permission to do so).    The number is 15376.  That is the IND # for the proposed phase I/II clinical trials, however when I scan through patents as well as the FDA site- I do not see any indication aside from BMSN being mentioned once on the FDA site, that there is any interaction between the two agencies.